Natural History Protocol for Movement Disorders
- Conditions
- Parkinson's DiseaseMovement DisorderTremor
- First Posted Date
- 2022-06-10
- Last Posted Date
- 2025-03-26
- Target Recruit Count
- 4000
- Registration Number
- NCT05413291
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
- Conditions
- Gulf War Illness
- First Posted Date
- 2022-05-17
- Last Posted Date
- 2025-07-04
- Target Recruit Count
- 85
- Registration Number
- NCT05375812
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2
- Conditions
- Systemic InflammationMicrovascular ThrombosisNeuroinflammation
- Interventions
- Drug: IV immunoglobulinDrug: IV normal saline
- First Posted Date
- 2022-04-28
- Last Posted Date
- 2025-04-01
- Target Recruit Count
- 45
- Registration Number
- NCT05350774
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Investigational Use of Neuromuscular Ultrasound
- Conditions
- Normal PhysiologyPeripheral NeuropathyMotor Neuron DisorderMuscular Dystrophy
- First Posted Date
- 2022-02-14
- Last Posted Date
- 2024-12-27
- Target Recruit Count
- 150
- Registration Number
- NCT05237973
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Non-invasive Intermittent Theta Burst Stimulation of the Dorsolateral Prefrontal Cortex in Functional Movement Disorders
- Conditions
- Functional Movement Disorder
- First Posted Date
- 2021-12-13
- Last Posted Date
- 2025-06-03
- Target Recruit Count
- 21
- Registration Number
- NCT05155059
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Data Collection of Standard Care of Patients in the EMG Section
- Conditions
- NeuropathyMuscle DisordersDysautonomia
- First Posted Date
- 2021-09-13
- Last Posted Date
- 2024-12-20
- Target Recruit Count
- 200
- Registration Number
- NCT05041387
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Clinical, Molecular and Imaging Biomarkers in Spinal and Bulbar Muscular Atrophy (SBMA)
- Conditions
- Spinal and Bulbar Muscular AtrophyKennedys DiseaseMotor Neuron Disease
- First Posted Date
- 2021-06-30
- Last Posted Date
- 2025-07-02
- Target Recruit Count
- 70
- Registration Number
- NCT04944940
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Teriflunomide in HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
- First Posted Date
- 2021-03-16
- Last Posted Date
- 2025-07-09
- Target Recruit Count
- 24
- Registration Number
- NCT04799288
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal Leukoencephalopathy
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2025-06-18
- Target Recruit Count
- 18
- Registration Number
- NCT04781309
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Tolebrutinib, a Brain-penetrant Bruton's Tyrosine Kinase Inhibitor, for the Modulation of Chronically Inflamed White Matter Lesions in Multiple Sclerosis
- Conditions
- Multiple Sclerosis
- Interventions
- Drug: tolebrutinib 60mgDrug: tolebrutinib 120mg
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2024-08-13
- Target Recruit Count
- 12
- Registration Number
- NCT04742400
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States